Residual 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine (18FDOPA) hypermetabolic burden predicted overall survival (OS) for isocitrate dehydrogenase (IDH) wild-type gliomas, regardless of the tumor grade. The gene discussed is IDH1; the disease is central nervous system cancer.